Classification of Progression Patterns in Glioblastoma: Analysis of Predictive Factors and Clinical Implications.

Front Oncol · 2020 · PMC7673412 · PMID 33251147

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

showed a trendP = 0.079so close (0.05 < p ≤ 0.1)

Supplementary Figure 2 In the subgroup of MGMT promoter methylation, patients with re-chemotherapy showed a trend toward better PPS comparing with those without re-chemotherapy (11.5 vs. 8.5 months, P = 0.079) (A) .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.